soluble IL-21 receptor decoys (Wyeth)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesoluble IL-21 receptor decoys (Wyeth)

Drug Alias NamesIL21Rfc

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionInterleukin-21 inhibitors

TargetsInterleukin-21

Therapy Area/IndicationsInflammationArthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesWyeth Research

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWyeth Research

Active IndicationsN/A

Inactive IndicationsInflammationArthritis

Other Information

ATC CodeN/A